Here, we have used a novel mouse model allowing the selective elimination of CD27-expressing Treg cells at a defined point in time to investigate the CD27-CD70 axis in Treg-mediated suppression of steady state DCs and anti-tumor immunity. This evidence concerns the gene CD27 and neoplasm.